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OBJECTIVES We conducted this study to compare the efficacy and safety of different catheter ablation
technologies and of distal versus ostial pulmonary veins (PV) isolation using the circular
mapping technique.
BACKGROUND Electrical isolation of the PVs in patients with atrial fibrillation (AF) remains a technical
challenge.
METHODS Two hundred eleven patients (163 men; mean age 53 11 years) with symptomatic AF were
included in this study. In the first 21 patients (group 1), distal isolation (5 mm from the
ostium) was achieved targeting veins triggering AF. In the remaining 190 patients (group 2),
ostial isolation of all PVs was performed using 4-mm tip (47 patients), 8-mm tip (21
patients), or cooled-tip (122 patients) ablation catheters.
RESULTS Distal isolation was able to eliminate premature atrial contractions (PACs) and AF in six of
21 patients (29%) and 10 of 34 PVs. After a mean follow-up time of 6  4 months, no
patients treated with the 8-mm tip catheter experienced recurrence of AF, whereas 21% (10
of 47 patients) and 15% (18 of 122 patients) of the patients ablated with the 4-mm tip and
the cooled-tip ablation catheters experienced recurrence of AF after a mean follow-up of 10
 3 and 4  2 months, respectively. Significant complications including stroke, tamponade,
and severe stenosis occurred in 3.5% (8/211) of patients.
CONCLUSIONS Catheter technologies designed to achieve better lesion size appeared to have a positive impact
on procedure time, fluoroscopy time, number of lesions, and overall efficacy. Although distal
isolation can be achieved with fewer lesions, ostial isolation is required in the majority of
patients to eliminate arrhythmogenic PACs and AF. (J Am Coll Cardiol 2002;40:464–74)
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Ablation of ectopic triggers of atrial fibrillation (AF) has
been reported to eliminate AF (1,2). Mainly, two different
strategies had been developed to map and eliminate pulmo-
nary veins (PVs) triggers: focal ablation targeting single or
multiple foci in the arrhythmogenic PV trunk, or electrical
isolation of the PV by circumferential PV lesions (1–4).
Recently, distal ablation of PV triggers applying segmental
lesions at the site of earliest conduction identified by
circumferential mapping technique has been suggested to be
effective (5). We initiated this study to compare the efficacy
and safety of different catheter ablation technologies in PV
isolation using circumferential mapping. Moreover, we
assessed the effect of distal isolation of the PVs in the initial
group of patients.
METHODS
Patients characteristics. Two hundred eleven patients
(163 men; mean age 53  11 years) with symptomatic
paroxysmal (113 patients), persistent (34 patients), and
permanent (64 patients) AF (duration 5.5  3.6 years) were
referred to our laboratory for electrophysiology study and
catheter ablation. All patients signed a written informed
consent. Data were collected based on a protocol approved
by the institutional ethics committee. All antiarrhythmic
drugs (3  1 drugs) were discontinued five half-lives before
the ablation. In all but three patients amiodarone was
withdrawn one month before the procedure. Structural heart
disease was present in 24% of patients (51/211). Immediately
prior to the procedure transesophageal echocardiography was
performed in all study patients. A spiral computerized tomog-
raphy (CT) scan was performed two or three months after the
procedure. In the first 21 patients (13 men, mean age 52 10
years) distal isolation was initially performed (group 1). In
addition, in group 1 only veins showing firing were targeted. In
the remaining 190 patients (group 2) (148 men, mean age 53
 11 years), ostial isolation was exclusively performed. In this
group all PVs were isolated.
Mapping and ablation catheters. Three multipolar elec-
trode catheters and a bipolar esophageal lead were used to
map beats triggering AF (6). A custom-made catheter
(Cardiac Assist Device Inc., Cleveland, Ohio) was placed in
the coronary sinus (CS). The proximal eight electrodes were
positioned between the superior vena cava (SVC) and the
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high crista terminalis, whereas the distal eight electrodes
were in the CS. A transesophageal recording lead was used
to record the left atrial posterior wall activation. Mapping of
left atrium (LA) and PVs was completed after approaching
the LA via the transseptal approach. Two separate trans-
septal accesses were obtained. A 6-French multielectrode,
deflectable tip circular catheter (Cardiac Assist Device Inc.)
with 2 mm interelectrode space in 76 patients, or a loop
catheter (Lasso, Biosense-Webster, Baldwin Park, Califor-
nia) with deflectable shaft in 135 patients were used to map
pulmonary vein potentials (PVPs). The diameter of the
circular loop of the deflectable tip and the Lasso catheter
ranged from 1 to 2.5 cm and 1 to 2.0 cm, respectively,
chosen to fit the PV circumference according to the pre-
ablation venogram. Depending on the diameter, the
custom-made circular mapping catheter (Cardiac Assist
Device Inc.) had 12, 14, or 16 electrodes.
In group 1, a quadripolar 4-mm tip (Biosense Webster)
ablation catheter was exclusively used for distal and ostial
PV isolation. Quadripolar 4-mm tip, 8-mm tip (Biosense
Webster), and cooled-tip catheters (EP Technologies,
Sunnyvale, California) were used for ablation in 47, 21, and
122 patients of group 2, respectively. In the first 95 patients
the 4-mm tip and the cooled tip catheters were used in
alternating fashion. The 8-mm tip catheter was used in 11
consecutive patients during the first month and in the other
10 patients during the third month of this experience. The
ostium of the PVs was confirmed by performing PV vein
angiography during adenosine (range 12 to 24 mg) induced
asystole. In addition, electrical mapping of PV- and LA
potentials was also used to target proximal lesions. In this
respect, any PVPs recorded in front of the LA-PV junction
defined by angiography were considered extension of the
PVs sleeves and were targeted for ablation. The PV angio-
gram was obtained in 30° left anterior oblique and 30° right
anterior oblique views. Fifteen to 20 cc of manually injected
contrast was used for each angiogram. Intravenous heparin
was titrated to maintain the activated clotting time 300 s
after the transseptal puncture.
Electrophysiologic study and ablation. In patients pre-
senting to the electrophysiology laboratory with sustained
AF, external DC cardioversion was performed. Before
ablation, isoproterenol infusion (2 to 20 g/min) was given
only to patients with no or few premature atrial contractions
(PACs). Isoproterenol infusion was initiated at a dose of
2 g/min for 3 min and then increased by 3 g/min every
2 min and up to 20 g/min until AF was initiated. Documen-
tation of single or multiple ectopies conducted from a certain
PV and initiating AF by rapid firing on at least three separate
occasions defined an arrhythmogenic PV. If circumferential
recording during sinus rhythm revealed double or multiple
potentials at a certain site, the first low-frequency spike was
considered LA potential, and the latest high-frequency spike
reflected PVP (Fig. 1). If LA potentials were superimposed to
the PVP, distal CS or right atrial pacing was performed to
achieve their separation. During ectopic beats a reversal of
activation was observed, that is, high-frequency PVP preceded
the LA potential (Fig. 1D).
Once origin from the right or left PVs was documented
(6), two circular mapping catheters were placed in the upper
and lower veins on the site of interest. After the PV with the
earliest activity conducted to the atrium was identified, the
circular multipolar catheter was positioned to map that
particular PV circumferentially. Circumferential mapping
was initiated in the distal PV trunk 5 mm from the PV-LA
junction, looking for the most distally recorded PVP (Fig.
1). During ectopies the earliest PVP was considered as the
origin of arrhythmogenic beat (Fig. 2). PV ostium mapping
was conducted after positioning the circular mapping cath-
eter at the junction between PV and LA defined based on
the PV angiogram and the intracardiac electrogram.
Distal isolation performed in group 1 was defined as
successful abolition of PVP mapped 5 mm from the ostium
of the arrhythmogenic PV (Figs. 3B and C). This approach
was initially considered because the circular mapping cath-
eter tended to be more stable inside the vein. Radiofre-
quency (RF) ablation was performed targeting the earliest
circumferentially recorded PVP during sinus rhythm or CS
pacing, and subsequently if needed targeting contiguous
sites showing earlier PVP. Ostial isolation (at the PV-LA
junction) was performed in the same fashion. Distal isola-
tion was performed only in the first 21 patients. Subse-
quently, considering the results observed in this group of
patients, ostial isolation was exclusively used in the remain-
ing 190 patients. For the purpose of documentation, the PV
circumference was divided into 16 sectors. Failure of distal
and/or proximal isolation to eliminate arrhythmogenic
PACs initiating AF was considered if we were still able to
record spontaneous or isoproterenol-induced (at a maxi-
mum dose of 20 g/min) AF originating from the targeted
veins despite successful circumferential abolition of PVPs.
Group 1 patients were not included in the analyses com-
paring different ablation technologies.
Target temperature was 55°C for the RF energy delivery
through the 4-mm and 8-mm tip catheters. A 35°C target
temperature was chosen for RF energy delivery through the
cooled-tip catheter. At each site energy was delivered for 40 s.
After ablation, PV venograms were repeated to assess for
stenosis. At the end of the procedure, patients were given a
crushed aspirin (325 mg) orally and coumadin was restarted.
Abbreviations and Acronyms
AF  atrial fibrillation
LA  left atrium
LLPV  left lower pulmonary vein
LUPV  left upper pulmonary vein
PAC  premature atrial contractions
PV  pulmonary vein
PVP  pulmonary vein potential
RLPV  right lower pulmonary vein
RUPV  right upper pulmonary vein
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Follow-up. If no complications occurred, patients were
discharged home next day. All patients were discharged on
oral anticoagulation (warfarin). Follow-up was scheduled at
one, three, six, and 12 months post ablation. After two to
three months, anticoagulation was stopped unless patients
experienced recurrence of AF, or if more than 70% narrow-
ing of the treated PV was proven by the spiral CT scan, or
if other thromboembolic risk factors were known. Patients
Figure 1. Pullback mapping in a right upper pulmonary vein using the circular mapping catheter shown in panel A. One cm inside the vein (B), pulmonary
vein potentials (PVPs) appeared barely present. Five mm from the ostium PVPs are recorded at T1, T2, T5, and T6 (C). Ultimately at the ostium, local
pulmonary vein (PV) electrograms are seen at every bipole except T4 (D). After ostial isolation, requiring 19 lesions, no local ostial PV activity is observed
(E). V1 and aVF represent surface electrocardiographic recordings. ESO  esophageal recording; hRA ds high right atrium (hRA ds applies to Fig. 3C);
CS  coronary sinus recording; T1–T6  distal to proximal bipolar recordings from the circular catheter (CC). Continued on next page.
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Figure 1. Continued from previous page.
were also monitored with Holter recording before dis-
charge, at three- and six-month follow-up. In case of
recurrence of symptoms, event recorder monitoring was also
considered. Recurrence during the first three weeks after
ablation was not considered a true recurrence unless it
persisted beyond that time frame. Two to three months
after the ablation, a spiral CT scan of the PVs was obtained
in all patients.
Statistical analysis. Continuous variables are expressed as
mean  SD. Continuous variables were compared by
Student t test. Differences among groups of continuous
variables were determined by analysis of variance. Categor-
ical variables were compared by Fisher exact test. A Kaplan-
Meier analysis with the log-rank test was used to determine
the probability of freedom from recurrent AF. A Cox
multivariate regression analysis was performed to determine
the clinical predictors of freedom from symptomatic AF. A
value of p  0.05 was considered statistically significant.
RESULTS
All patients had documentation of symptomatic episodes of
paroxysmal (113 patients), persistent (34 patients), or per-
manent (64 patients) AF on several 24-h Holter monitor
recordings (median number of Holter 3, range 2 to 5). One
hundred ten patients presented to the electrophysiology
laboratory in sinus rhythm (SR), 90 were in AF, and 11 in
atrial flutter/fibrillation. In 22 of 110 patients in SR,
spontaneous ectopies and AF were documented. DC car-
dioversion was followed by spontaneous reinitiation of AF
in 40 of the 101 patients with sustained AF or flutter.
Isoproterenol was applied for the initiation of APCs and AF
in 15 patients in group 1 and in the first 51 patients in group
2. In 71% of group 1 patients and 69% of group 2 patients,
in whom isoproterenol was administered pre-ablation, iso-
proterenol was required to initiate ectopies triggering AF.
Table 1 illustrates patients’ characteristics.
Pulmonary vein ectopy. In group 1, arrhythmogenic ec-
topic foci originated from a single vein in 12 patients, from
two veins in six patients, from three veins in two patients,
and from four veins in another patient, for a total of 34
arrhythmogenic PV foci in 21 patients.
In group 2, arrhythmogenic ectopic foci originated from
a single vein in 65 patients. Firing from two veins occurred
in 47 patients, from three veins in 31 patients, and from four
veins in 19 patients, for a total of 330 arrhythmogenic PV
foci in 190 patients. This included 110 right upper pulmo-
nary veins (RUPV), 122 left upper pulmonary veins
(LUPV), 36 right lower pulmonary veins (RLPV), and 62
left lower pulmonary veins (LLPV). In group 2 all PVs were
isolated regardless of the mapping information.
Figure 1. Continued from previous page.
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Distal and ostial isolation. Distal isolation was performed
in the first 21 patients (group 1). As mentioned before, this
approach was considered because the circular catheter was
more stable when distally deployed. Lesions were delivered
targeting the site with the earliest activation on the circular
mapping catheter in 34 arrhythmogenic PVs. RF energy was
delivered using the 4-mm tip ablation catheter 6 2 mm into
the RUPV, 5  2 mm into the LUPV, 7  1 mm into the
RLPV, and 6  1 mm into the LLPV. A mean of 5  2 RF
(3  1 min) were needed for distal isolation (Table 2). After
distal isolation, PV ectopies initiating AF from the treated vein
were still present in 15 (71%) of 21 patients (Fig. 3C). In veins
still capable of initiating ectopies and AF after distal isolation
(24 of 34 PVs), ostial isolation was conducted. In 1 LUPV
ostial isolation was not attempted because of evidence of nearly
complete occlusion after distal ablation.
Ostial isolation was performed in 712 PVs in group 2. In
one patient the procedure was terminated due to evidence of
neurologic embolic event before proximal isolation of the
RUPV was achieved. In 48 patients (25%) angiographic
evidence of a single ostium of either both left PVs (32
patients, 17%) or both right PVs (16 patients 8%) was
documented. To obtain ostial isolation, a mean of 10  4
RF lesions (8.6  2 min) per vein were delivered.
After ostial isolation, no PACs triggering AF were
initiated from all but one PV despite an average infusion
rate of isoproterenol of 14.3  4.7 g/min in group 2. In
one patient, isolation of a large RUPV ostium appeared
difficult and was abandoned because of evidence of neuro-
logic embolic event. The mean procedure and fluoroscopy
times were significantly lower using the 8-mm tip (3  1 h
and 51  8 min) and cooled-tip (4.6  1 h and 88  24
min) ablation catheter compared with the 4-mm tip (5.5 
3 and 110  40 min) ablation catheter (Table 2), p  0.05.
The procedure time included the transesophageal echocar-
diogram performed in the laboratory before the ablation.
Initiation of premature atrial contractions and AF with
isoproterenol. Seventy-one percent of group 1 patients
(15/21) and 69% of group 2 patients (35/51) required
isoproterenol for initiation of ectopies triggering AF. Pre-
ablation the mean dose of isoproterenol needed for induc-
tion was 14  2 g/min. None of the patients had AF at a
dose of 2 g/min. After isolation of the culprit arrhythmo-
genic PV, firing from a different vein was seen with a mean
isoproterenol of 9.2  2.2 g/min (range 6 to 10 g/min)
and 17.2  4.2 g/min (range 10 to 20 g/min) in 24%
(5/21) and 35% (7/21) of group 1 patients, and 8.2  3.2
g/min (range 6 to 10 g/min) and 16.2  4.2 g/min
Figure 2. Intracardiac recordings showing concealed premature atrial contraction (PAC), which eventually managed to activate the atrium and initiate AF.
Differently from what we observed distally in the vein, ostial initiations appeared to have a more longitudinal activation sequence. Note simultaneous activation
in T1, T2, T3, T6, and T7. Bipole T4 does not record any PVP, but appeared to correspond to the take off of a branch. See Figure 1 for abbreviations.
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(range 10 to 20 g/min) in 28.5% (54/190) and 40%
(76/190) of group 2 patients, respectively. Isoproterenol-
induced PACs post PVs isolation in group 1 originated
from the SVC in two patients and from different PVs in 10
patients. A mean isoproterenol infusion rate of 12  3
g/min, 15  4 g/min, and 17  3 g/min could induce
arrhythmogenic PACs from two PVs in five patients, from
three PVs in three patients, and from four PVs in two
Figure 3. Intracardiac recordings from the circular mapping catheter placed in the RUPV as shown in panel A. Deployment of the catheter 5 mm from the ostium
demonstrated early local PV activation at the T5, T6 bipolar recordings (B). Distal isolation (C) was achieved with four lesions directed in the proximity of the
T5, T6 segments. Note the absence of PVPs from T1 to T6 recordings on the circular catheter. However, AF is not yet abolished and appeared to originate
more proximally. In this patient successful elimination of AF was obtained by ostial isolation. OCT1–OCT4  distal to proximal longitudinal bipolar
recordings. See Figure 1 for other abbreviations. Continued on next page.
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patients in group 1. The arrhythmogenic PACs originated
from the left atrial posterior wall in the proximity of the
RUPV in two, from the SVC in 10, and from a different PV
in 117 group 2 patients. A mean isoproterenol infusion rate
of 13  3 g/min, 16  4 g/min, and 18  3 g/min
could induce arrhythmogenic PACs from two PVs in 48
patients, from three PVs in 29 patients, and from four PVs
in 12 patients.
Circumferential distribution of ostial PV potentials. The
ostial circumference of the PVs was divided into 16 sectors
based on the maximum number of electrodes present on the
2-cm loop catheter. The number of sectors showing PVPs
on the circular catheter, at which RF energy was delivered to
complete ostial isolation, were documented. PVPs were seen
and required ablation in all infero-anterior sectors of the
RUPV ostia. Distal and ostial isolation data are presented in
Table 3.
Complications and follow-up. Pulmonary vein venograms
performed immediately after distal isolation in group 1
showed 70% narrowing of the LUPV in one patient and
RUPV in one patient, respectively. Moderate stenosis (50%
to 70% narrowing) of the LUPV was seen in two patients,
and mild narrowing (50%) of two LUPV, one RUPV, and
one LLPV in four patients. In group 1, the spiral CT scan
Figure 3. Continued from previous page.
Table 1. Patients’ Demographics
Patient Characteristics Group 1 Group 2
No. of patients 21 190
Mean age (range), yrs 52  10 (25–70) 53  11 (24–75)
Gender, male/female 13/8 142/48
AF: paroxysmal/persistent/chronic 16/3/2 102/29/59
Duration of AF, yrs 3  3 (0.5–5) 5.5  3.6 (0.5–14)
Structural heart disease, n 5 46
Hypertension 6 15
Sick sinus syndrome 2 12
Left atrial diameter, mm 4.1  0.9 4.3  0.6
Left ventricular ejection fraction, % 56  10 53  6
Number of failed AAD 3  1 3  1
AAD  antiarrhythmic drugs; AF  atrial fibrillation.
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showed severe PV stenosis in three patients, one of whom
had stenosis in both the LUPV and LLPV. All three
patients had dilatation. Among the patients undergoing
ostial isolation (group 2), mild stenosis (50% narrowing)
was seen in 12 patients. Moderate stenosis was seen in six
patients. Severe stenosis was seen in the left superior PV of
one patient, and in the left inferior PV in another patient,
one of whom had undergone a repeat ablation procedure.
One patient developed aphasia documented at the end of
the ablation, which nearly resolved after 48 h. Another
patient developed right-sided hemiplegia, which nearly
resolved after one week. Two patients developed tamponade
due to right atrial perforation in one patient and CS
perforation in the other patient. Only the latter patient
underwent emergency open heart surgery.
During a mean follow-up time of 11  3 months, AF
recurrence was documented in five patients (24%) in group
1. Four of these patients underwent repeat procedure during
which recurrence appeared associated with firing from veins
not targeted during the first procedure. The fifth patient
with recurrence was the one with a large LLPV, which
could not be proximally isolated during the initial proce-
dure. This patient underwent a second procedure with a
larger custom-made circular catheter and was cured.
Figure 4 demonstrates the arrhythmia-free survival curve
of group 2 patients based on the ablation catheter used. In
Tables 2 and 4 the mean follow-up time and recurrences in
group 2 patients related to the ablation catheter used and
type of AF are shown. After a mean follow-up time of 8 
4 months, all patients treated with the 8-mm tip catheter
had no recurrence of AF, whereas 21% (10 of 47 patients)
and 15% (18 of 122 patients) of the patients ablated with the
4-mm tip and the cooled-tip ablation catheters had recur-
rence of AF after a mean follow-up of 10  3 and 4  2
months, respectively. Fifteen of these patients underwent
repeat procedure during which recurrence appeared associ-
ated with firing from previously treated PVs in nine pa-
tients. In four patients treated with amiodarone up to one
month or less before ablation, veins targeted during the first
procedure showed recovered conduction in segments elec-
trically inactive during the first procedure. Firing from a
focus in the posterior wall of the LA in the vicinity of the
RUPV ostium was responsible for recurrence in two pa-
tients. Ten patients responded to previously ineffective drug
therapy. Three patients still have AF and are waiting for a
second procedure. One patient with a single right PV
ostium (ostium larger than 4 cm) and large electrically silent
areas in the LA did not improve after ablation.
Table 3. Number of Sectors Isolated in Relation to Distal or Ostial Pulmonary Vein Isolation
RUPV RLPV LUPV LLPV Total
Distally isolated pulmonary veins 14 1 11 8 34
Sectors
0–4 28% 100% 14% 10%
5–8 56% 0% 60% 51%
9–12 11% 0% 22% 35%
13–16 0% 0% 4% 0%
Ostially isolated pulmonary veins 190 174 190 158 712
Sectors
0–4 0% 6% 1% 3%
5–8 9% 20% 10% 15%
9–12 22% 33% 12% 30%
13–16 69% 41% 77% 52%
LLPV  left lower pulmonary vein; LUPV  left upper pulmonary vein; RLPV  right lower pulmonary vein; RUPV  right upper pulmonary vein.
Table 2. Group 2 Patients Separated According to Ablation Catheter Used
Radiofrequency
4-mm Tip 8-mm Tip Cooled-Tip
Patients 47 21 122
Age 53  13 56  8 54  11
SHD 19% (9/47) 20% (4/21) 27% (33/122)
Fluoroscopy time (min) 110  40 51  8* 88  24*†
Procedure time (h) 5.5  3 3  1* 4  1*
Lesions/PV (min) 15  3 lesions 5  2 lesions* 7  4 lesions
(10  2) (3  1) (4.5  2.5)
Follow-up (months) 10  3 8  4 4  2*
Recurrence 10 (21%)† none 18 (15%)†
Stroke 2% (1/47) none 1% (1/122)
Tamponade none none 1.5% (2/122)
Severe PV stenosis 2% (1/47) none 1% (1/122)
*p  0.05 versus 4-mm tip; †p  0.05 versus 8-mm tip.
PV  pulmonary vein; SHD  structural heart disease.
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DISCUSSION
Primary finding. In the present study, with the use of
circumferential mapping of the PVs we were able to
demonstrate that distal isolation could be achieved with
segmental ablation of the PV circumference, whereas nearly
complete circumferential ablation of the PV ostium is
needed in the majority of patients to achieve ostial isolation.
Moreover, distal isolation was able to eliminate APCs and
AF onset originating from the treated vein in only 29% of
the patients treated with this approach. Despite the smaller
number of patients treated with the 8-mm tip catheter, this
technology appears to be superior to the 4-mm tip and
cooled-tip ablation catheters in terms of AF recurrence, fluo-
roscopy, and procedure time. Because of the higher stenosis
and recurrence rates after distal isolation compared with the
ostial isolation, only ostial isolation was performed in the last
190 study patients. Another important finding in our study is
that isolation of focal triggers from the PV is effective in
achieving cure in patients presented with AF independently
from the duration of the arrhythmia and the LA size.
Mapping and ablation. The strategy most commonly used
to map and ablate PVPs that trigger focal AF is the
application of RF energy at the source or exit site of these
triggers using longitudinal mapping (2,7). Chen et al. (2)
reported that 61% of PV triggers initiated distally (20
mm) inside the PV and the rest were located around the
ostium. Despite successful distal isolation of the arrhyth-
mogenic PV in all our patients, unlike Chen’s data, we
demonstrated that the majority of the arrhythmogenic PV
triggers (71%) were still firing from the PV. It is difficult to
compare our study results with those published by Chen et
al. (2), because two different mapping techniques were used
to locate the arrhythmogenic triggering site. Chen et al. (2)
used longitudinal mapping with one single multipolar cath-
eter placed in the PV. Using this approach only a certain
segment or sector of the PV could be simultaneously
mapped, which could have resulted in misleading results. In
our study the use of circular mapping was applied to record
the activation of the whole PV circumference simulta-
neously. Another possible reason for the differences between
our data and those documented by Chen could be the
different approach applied in our study to assess ablation
success. We applied high doses of isoproterenol (up to 20
g/min) to prove that distal or ostial isolation of the treated
PV was successful in eliminating PACs and AF. In the
distally isolated PVs, 60% of the PACs were induced from
the PV ostium at an isoproterenol dose greater than 10
g/min. The maximum isoproterenol dose applied by Chen
and others to assess successful ablation was 6 g/min.
Haı¨ssaguerre et al. reported a similar circular mapping
technique of PVP. This approach provided permanent
monitoring of PVPs during ablation allowing the applica-
tion of RF energy at segments considered critical to con-
duction distal to the mapping point (5), so that isolation
could be achieved with fewer strategically placed lesions.
More specifically, they suggested that with circular mapping
ablation lesions could be directed to sites showing earliest
local PVPs. These sites may represent preferential conduc-
tion pathways, ablation of which could achieve PV isolation
with a limited number of lesions.
Similarly to Haı¨ssaguerre and co-workers’ series, in our
series distal isolation could be obtained with few lesions
targeting segments showing preferential conduction. On the
other hand, ostial isolation required ablation lesions around
most of the vein circumference depending on the treated
PV. In addition, in our series we demonstrated the inability
of distal isolation to eliminate PACs and AF in nearly 71%
of patients with focal AF. Complete ostial isolation was
Figure 4. Atrial fibrillation free survival curves after pulmonary veins
isolation in patients ablated with the 4-mm tip (dashed line), the 8-mm tip
(dotted line), and the cooled-tip (solid line) catheter are shown. Recur-
rence rate appeared to be higher with the 4-mm tip catheter (p  0.05).
Table 4. Group 2 Patients Separated According to Type of Atrial Fibrillation
Paroxysmal AF Persistent AF Permanent AF
Patients 102 29 59
Mean age (yrs) 53  11 52  8 65  12*
Mean duration of AF (yrs) 4  2 4  4 7  4*
Left atrial diameter (mm) 4  0.5 4  0.6 4.7  0.7*
Follow-up (months) 9  3 7.5  4 7.5  2
Recurrence 15% (15/102) 17% (5/29) 14% (8/59)
Chronic cure 94% (96/102) 90% (26/29) 89% (54/59)
Controlled on AAD 4% (4/102) 10% (3/29) 7% (4/59)
p  0.05 versus paroxysmal and persistent AF.
AAD  antiarrhythmic drugs; AF  atrial fibrillation.
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indeed needed to abolish the arrhythmogenic foci respon-
sible for AF in the majority of patients.
Risk of stenosis. Focal ablation within the PV has been
associated with PV stenosis (3,8). Haı¨ssaguerre et al. reported
3% PV stenosis rate after RF energy delivery in the PV. Lin et
al. (3) reported the presence of significant narrowing in 42% of
focally ablated patients. Robbins et al. reported 11% PV
stenosis during a multicenter trial for treatment of chronic AF,
where lesions were mainly delivered in the PV (9). In our
series, distal isolation showed chronic severe stenosis in three of
21 patients (14%). Of the 190 patients receiving ostial isolation
only two (1%) had significant stenosis. It is conceivable that
ostial isolation will reduce the occurrence of this complication.
This could reflect the thickness of the PV ostium and lack of
PV smooth muscle cells in that region, which could respond
with scarring and contraction to thermal injury.
Pulmonary veins isolation with different catheter tech-
nologies. The use of 8-mm tip and cooled-tip ablation
catheters appeared to be associated with significantly shorter
fluoroscopy time, procedure time, and number of delivered
lesions compared with the conventional 4-mm tip approach.
This can be explained by the larger lesions created by the
8-mm tip and cooled-tip (10) ablation catheters. Of inter-
est, in our preliminary experience there were no recurrences
in the group of patients treated with the 8-mm tip catheter.
The PV muscular sleeves are extensions of left atrial fibers
originating before the PV-LA junction as reported by Ho et al.
(11) and Saito et al. (12). Applying RF energy at the PV-LA
junction using the 8-mm tip may ablate more effectively the
extension of the PV sleeves into the LA. This tissue could be
relevant to the initiation of AF, and ablation of the more
proximal portion of the PV sleeves may be responsible for the
better success seen with the 8-mm tip catheter.
Pulmonary veins isolation in paroxysmal, persistent, and
chronic AF. A few studies have reported on the effect of
PV isolation in treating patients with paroxysmal AF
(2,4,7). Less information is available in patients presenting
with chronic AF (13). Recently Haı¨ssaguerre and co-workers
demonstrated a 60% long-term success after PV isolation in
patients with chronic AF. Left atrial diameter has been shown
to be an important factor in determining the response of AF to
therapy (14,15). In the present study, isolation of focal triggers
initiating in the PV appeared an effective cure for AF inde-
pendently from the duration and left atrial size. Indeed around
80% of patients presenting with chronic AF and dilated LA
were still in sinus rhythm at follow-up.
Limitations. This study was not randomized. In addition,
only a small number of patients was ablated using the 8-mm
tip ablation catheter. We did not consider mild or moderate
narrowing as clinically important. A longer follow-up is
needed to assess the significance of this finding.
Conclusion. The reported recurrence rates of AF after
focal ablation have been quite high, with the majority of
patients requiring two or more procedures (1–3). Overall,
the results obtained in the present study with circular
mapping are encouraging. Circular mapping–guided abla-
tion appeared to simplify and facilitate isolation of the PVs.
Although distal isolation can be achieved by limited ablation
lesions, it appears to have a higher risk of stenosis and it may
be effective in only a third of the patients. It appears imperative
that an effort is made to deliver lesions only at the ostium to
avoid or limit PV stenosis, which remains a problem if one
applies RF lesions at the sites where the circular catheter is
more stable. Delivering RF energy with an 8-mm tip catheter
seems to be a promising approach that improves success rate
and decreases both procedure and fluoroscopy times.
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